By Chris Wack
Graphite Bio Inc. said it named Alethia Young as its new chief financial officer.
The company said Ms. Young previously worked at Cantor Fitzgerald, where she served as senior biotech analyst and head of research, managing the equity research department covering small-cap, mid-cap and large-cap biotechnology companies.
Ms. Young would oversee the Graphite Bio’s finance, investor-relations and corporate-communications functions, and would play a key role in overall corporate strategy, the company said.
Ms. Young is expected to begin at the company April 1, Graphite Bio said.
Write to Chris Wack at chris.wack@wsj.com
